Chan R D, Greenstein S M, Sablay L, Alfonso F, Tellis V, Spitzer A, Greifer I, Corey H E
Department of Pediatrics, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.
Acta Cytol. 1995 May-Jun;39(3):435-42.
On their surface, renal tubular cells present intercellular adhesion molecule-1 (ICAM-1) during acute renal allograft rejection. We propose that the extent of ICAM-1 expression by renal tubular cells can be estimated from urine immunocytology. To test this hypothesis, we obtained 52 samples of urine from 31 renal transplant recipients with either acute tubular necrosis, rejection or stable renal function. Cytocentrifuged aliquots of urinary sediment were incubated with monoclonal antibodies to ICAM-1 in an avidin-biotin-peroxidase technique. To corroborate our findings, biopsy specimens were obtained for conventional and immunohistology one hour following vascular anastomosis and during rejection episodes. The proportion of renal tubular cells that expressed ICAM-1 was low in patients with acute tubular necrosis (23.8 +/- 3.6%) and high in patients with rejection (53.1 +/- 4.4% [SEM]) (P < .001). In 11 patients who recovered from rejection, the proportion of ICAM-1-positive renal tubular cells decreased from 55.9 +/- 5.6% to 25.5 +/- 4.3% (P < .05). In two patients who initially had acute tubular necrosis and then rejected their transplants, the expression of ICAM-1 on renal tubular cells tended to increase (from 27.5 +/- 2.5% to 60.0 +/- 20.0%, P = .12). In eight patients with acute tubular necrosis who never rejected their transplants, ICAM-1 expression remained low (23.1 +/- 3.8%). Immunocytology correlated well with immunohistology and the clinical diagnosis. Our findings suggest that urine immunocytology may be useful in monitoring adhesion molecule expression by renal tubular cells.
在急性肾移植排斥反应期间,肾小管细胞表面会出现细胞间黏附分子-1(ICAM-1)。我们提出,可以通过尿液免疫细胞学来估计肾小管细胞ICAM-1的表达程度。为了验证这一假设,我们从31例肾移植受者中获取了52份尿液样本,这些受者分别患有急性肾小管坏死、排斥反应或肾功能稳定。采用抗生物素蛋白-生物素-过氧化物酶技术,将尿沉渣的细胞离心涂片等分样本与抗ICAM-1单克隆抗体一起孵育。为了证实我们的发现,在血管吻合术后1小时以及排斥反应发作期间,获取活检标本进行常规组织学和免疫组织学检查。急性肾小管坏死患者中表达ICAM-1的肾小管细胞比例较低(23.8±3.6%),而排斥反应患者中该比例较高(53.1±4.4%[标准误])(P<.001)。在11例从排斥反应中恢复的患者中,ICAM-1阳性肾小管细胞的比例从55.9±5.6%降至25.5±4.3%(P<.05)。在2例最初患有急性肾小管坏死随后发生移植排斥的患者中,肾小管细胞上ICAM-1的表达有增加趋势(从27.5±2.5%增至60.0±20.0%,P = 0.12)。在8例从未发生移植排斥的急性肾小管坏死患者中,ICAM-1表达仍较低(23.1±3.8%)。免疫细胞学与免疫组织学及临床诊断相关性良好。我们的研究结果表明,尿液免疫细胞学可能有助于监测肾小管细胞黏附分子的表达。